
Drug Shows Promise as New Treatment for MS
The drug rituximab reduces disease activity in people with the relapsing-remitting form of multiple sclerosis (MS), according to two new studies. Rituximab selectively targets and depletes a subset of immune cells called B-cells by targeting a specific protein on the cell surface....